Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

The Pathogenic Potential of Campylobacter concisus Strains Associated with Chronic Intestinal Diseases

  • Nadeem O. Kaakoush,

    Affiliation School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, New South Wales, Australia

    ⨯
  • Nandan P. Deshpande,

    Affiliation Systems Biology Initiative, The University of New South Wales, Sydney, New South Wales, Australia

    ⨯
  • Marc R. Wilkins,

    Affiliations School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, New South Wales, Australia, Systems Biology Initiative, The University of New South Wales, Sydney, New South Wales, Australia

    ⨯
  • Chew Gee Tan,

    Affiliation School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, New South Wales, Australia

    ⨯
  • Jose A. Burgos-Portugal,

    Affiliation School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, New South Wales, Australia

    ⨯
  • Mark J. Raftery,

    Affiliation Biological Mass Spectrometry Facility, The University of New South Wales, Sydney, New South Wales, Australia

    ⨯
  • Andrew S. Day,

    Affiliations Department of Paediatrics, University of Otago (Christchurch), Christchurch, New Zealand, Department of Gastroenterology, Sydney Children's Hospital, Sydney, New South Wales, Australia

    ⨯
  • Daniel A. Lemberg,

    Affiliation Department of Gastroenterology, Sydney Children's Hospital, Sydney, New South Wales, Australia

    ⨯
  • Hazel Mitchell

    H.Mitchell@unsw.edu.au

    Affiliation School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, New South Wales, Australia

    ⨯

Abstract

Campylobacter concisus has garnered increasing attention due to its association with intestinal disease, thus, the pathogenic potential of strains isolated from different intestinal diseases was investigated. A method to isolate C. concisus was developed and the ability of eight strains from chronic and acute intestinal diseases to adhere to and invade intestinal epithelial cells was determined. Features associated with bacterial invasion were investigated using comparative genomic analyses and the effect of C. concisus on host protein expression was examined using proteomics. Our isolation method from intestinal biopsies resulted in the isolation of three C. concisus strains from children with Crohn's disease or chronic gastroenteritis. Four C. concisus strains from patients with chronic intestinal diseases can attach to and invade host cells using mechanisms such as chemoattraction to mucin, aggregation, flagellum-mediated attachment, “membrane ruffling”, cell penetration and damage. C. concisus strains isolated from patients with chronic intestinal diseases have significantly higher invasive potential than those from acute intestinal diseases. Investigation of the cause of this increased pathogenic potential revealed a plasmid to be responsible. 78 and 47 proteins were upregulated and downregulated in cells infected with C. concisus, respectively. Functional analysis of these proteins showed that C. concisus infection regulated processes related to interleukin-12 production, proteasome activation and NF-κB activation. Infection with all eight C. concisus strains resulted in host cells producing high levels of interleukin-12, however, only strains capable of invading host cells resulted in interferon-γ production as confirmed by ELISA. These findings considerably support the emergence of C. concisus as an intestinal pathogen, but more significantly, provide novel insights into the host immune response and an explanation for the heterogeneity observed in the outcome of C. concisus infection. Moreover, response to infection with invasive strains has substantial similarities to that observed in the inflamed mucosa of Crohn's disease patients.

Citation: Kaakoush NO, Deshpande NP, Wilkins MR, Tan CG, Burgos-Portugal JA, Raftery MJ, et al. (2011) The Pathogenic Potential of Campylobacter concisus Strains Associated with Chronic Intestinal Diseases. PLoS ONE 6(12): e29045. https://doi.org/10.1371/journal.pone.0029045

Editor: Dipshikha Chakravortty, Indian Institute of Science, India

Received: September 16, 2011; Accepted: November 18, 2011; Published: December 14, 2011

Copyright: © 2011 Kaakoush et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This work was supported by the National Health and Medical Research Council, Australia (grant number APP510113). NPD and MRW wish to acknowledge funding support from the Education Investment Fund Super Science Scheme, the New South Wales State Government Science Leveraging Fund and The University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

The human host first comes in contact with a rich array of intestinal bacteria, both non-pathogenic and potentially pathogenic, at the surface of the thick mucus layer that covers the mucosal surface of the intestine. Under specific conditions, some of these bacteria can penetrate the mucus layer, adhere to and invade the mucosa, and subsequently cause chronic intestinal diseases.

Crohn's disease (CD) is one of two major types of inflammatory bowel diseases. It is a chronic, relapsing active inflammatory disease affecting any part of the human gastrointestinal tract. Currently, the major differential diagnosis of CD from acute and self-limited gastroenteritis relies upon the presence of particular pathological findings including acute and chronic inflammatory cell infiltrates, the branching of intestinal crypts, granulomata and remodelling of the epithelial layer as well as the presence of symptoms for several weeks and recurrent symptomatic bouts of disease [1], [2]. Despite much research over many decades, no consensus has been reached regarding its etiology, however, there is strong evidence to support the role of bacteria in this disease [3].

It has been postulated that mucosa-associated bacteria (MAB) due to their morphological and motility features may penetrate and break the mucus barrier, thus allowing them to adhere to, invade, and subsequently colonize the intestinal mucosa layer [4]. These MAB include the spiral-shaped Campylobacter species, many of which are equipped with corkscrew-like motion that allows them by means of their flagella to move through the mucus layer to the epithelial surface [5].

In 2009, Zhang et al [6] reported the molecular detection of Campylobacter species in biopsy samples of children with newly diagnosed CD and controls. Interestingly, C. concisus DNA was found to be significantly more prevalent in children with CD (51%) than in controls (2%). Importantly in this study, C. concisus UNSWCD was isolated from a child with CD, providing evidence that in the early stages of CD, viable C. concisus species are present in the intestinal tracts of CD children. In 2010, further support for the possible role of C. concisus in CD was provided in a study by Man et al who reported the prevalence of C. concisus to be significantly higher in fecal samples of CD children as compared with that in non-CD inflammatory and healthy control groups [7]. Studies on C. concisus UNSWCD showed that this strain had an increased ability to invade the intestinal cell line Caco-2 as compared with strains isolated from patients with acute gastroenteritis and healthy controls [8]. In addition, a range of virulence factors have been identified to be secreted by C. concisus UNSWCD, including a RTX toxin and an outer membrane fibronectin binding protein [9].

Given that the current literature suggests that C. concisus is genetically and taxonomically diverse [4], [10], further studies investigating whether other isolates from chronic intestinal diseases have similar invasive abilities as the UNSWCD strain were required. In this study, a method to isolate MAB from intestinal biopsies of patients with chronic intestinal diseases and healthy controls was developed and, the ability of eight C. concisus strains isolated from patients with chronic intestinal diseases (three of which were isolated in this study) to adhere to and invade intestinal epithelial cells was investigated. The feature that likely confers the invasive phenotype of C. concisus was elucidated. Furthermore, we examined the effect of C. concisus UNSWCD on the protein expression in the human intestinal epithelial cell-line, Caco-2, using two dimensional (2D) gel electrophoresis coupled with tandem mass spectrometry. The regulation of inflammatory pathways identified through proteomics were confirmed with ELISA.

Materials and Methods

Isolation of mucosa-associated bacteria from intestinal biopsies

A method to isolate MAB from intestinal biopsies based on a two-step enrichment-filtration procedure was developed. For the enrichment step, Ham's F-12 was employed as an enrichment broth as this medium had been reported to have the unique property of providing stable growth of Helicobacter pylori even without the addition of serum [11]. The second step involved filtration of the complex growth mixtures from the enrichment broth through size-specific porous membranes that allowed for the separation of highly motile MAB from other non-motile or less motile bacteria [12]. Mucosal biopsy specimens from symptomatic children undergoing colonoscopy at the Sydney Children's Hospital (Randwick, Australia) were collected from an area adjacent to areas of inflammation within the ileo-colonic region of the intestine. Biopsy specimens were enriched in 3 ml Ham's F-12 media (Invitrogen) containing 5% fetal bovine serum (FBS) and vancomycin (10 µg ml−1) for 48 h at 37°C after which 200 µl of the growth mixture was filtered through a 0.6 µm Whatman filter (Interpath Services) onto Horse Blood Agar containing vancomycin (10 µg ml−1) and incubated at 37°C under microaerobic conditions generated by a Campylobacter gas generating system (Oxoid) for a further 48 h. Colonies were visualized under phase contrast microscopy and near complete 16S rRNA gene sequencing using the primers F27 and R1494 [13] was performed on all colonies of interest (spiral morphology).

Ethics approval

This study was approved by the Research Ethics Committees of the University of New South Wales and the South East Sydney Area Health Service-Eastern Section, Sydney (Ethics No.: 06/164). Written consent was obtained from all subjects, or their guardians, participating in this study.

Bacterial species and strains, and growth conditions

Campylobacter concisus strains UNSWCD, UNSW1, UNSW2, UNSW3, ATCC 51561, ATCC 51562, UNSWCS and BAA-1457 were used in this study. All strains were grown on Horse Blood Agar (HBA) plates [Blood Agar Base No. 2 supplemented with 6% defibrinated horse blood (Oxoid)], and incubated at 37°C under microaerobic conditions for 48 h. Salmonella Typhimurium LT2 and Escherichia coli K-12 were grown on Nutrient agar (Oxoid) under atmospheric conditions at 37°C for 24 h.

Cell culture

Three cell lines were used in this study, the human intestinal epithelial cell line Caco-2 (American Type Culture Collection; HTB-37), the human mucin producing intestinal cell line LS174T (American Type Culture Collection; CL-188) and the human monocytic leukemia THP-1 cell line (ATCC No.: TIB-202).

Caco-2 cells

Cells were grown in 10 ml cell culture media comprised of Minimum Essential Medium (MEM), (Invitrogen) supplemented with 10% FBS, 1 mM sodium pyruvate, 0.1 mM non-essential amino acids, 2.25 mg 1−1 sodium bicarbonate and 100 µg ml−1 penicillin and streptomycin (Invitrogen) in 25 cm2 tissue culture flasks (In Vitro Technologies; Noble Park, VIC, Australia) at 37°C with 5% CO2. After 1 week of culture, cells were harvested by trypsinization. Cells were either passaged at a concentration of 1×105 cells ml−1 into 25 cm2 tissue culture flasks and maintained for a week or seeded at a concentration of 5×105 cells ml−1 into 24-well plates and kept for 2 days at 37°C with 5% CO2 in order to form a confluent monolayer for the adherence and invasion assays. Prior to seeding, the wells were coated with 1 ml collagen (0.338 mg ml−1) and incubated for 20 min at 37°C with 5% CO2.

Intestinal cell line LS174T

Cells were grown in 10 ml cell culture media comprising Roswell Park Memorial Institute (RPMI)-1640 medium (Invitrogen) supplemented with 10% FBS and 100 µg ml−1 penicillin and streptomycin in 25 cm2 tissue culture flasks at 37°C with 5% CO2. After 2 days of culture, cells were harvested by trypsinization. Cells were then either passaged at a concentration of 5×105 cells ml−1 into 25 cm2 tissue culture flasks and kept for 2 days or seeded at a concentration of 5×105 cells ml−1 into 24-well plates and kept for 2 days to form a confluent monolayer. The confluent monolayer was incubated at 37°C with 5% CO2 for an extra 3 days to allow the development of a mucin layer for the adherence and invasion assays. The medium was changed daily until the development of a mucin layer.

THP-1 cells

Cells were cultured in RPMI 1640 medium containing 2 mM L-glutamine (Invitrogen) supplemented with 10% FBS, 1 mM sodium pyruvate, 2.25 mg l−1 sodium bicarbonate and 100 U ml−1 penicillin and streptomycin. After 1 week of culture, cells were harvested by centrifugation. Cells were either passaged at a concentration of 2×105 cells ml−1 into 25 cm2 tissue culture flasks and maintained for a week or seeded at a concentration of 2×105 cells ml−1 with 250 nM phorbol 12-myristate 13-acetate (PMA) into 96-well plates to differentiate into macrophages. Following incubation for 2 days, the media with 250 nM PMA was replaced and the cells were used for ELISA assays the following day.

Gentamicin protection (invasion) and adherence assays

Monolayers were infected with the bacteria at a Multiplicity of Infection (MOI) of 200. Following the addition of the bacteria, the 24-well plates were centrifuged at 232× g for 5 min to promote bacterial-human cell contact. Infected monolayers were then co-incubated with the bacteria for 6 h at 37°C with 5% CO2 to allow adherence and invasion to occur.

Invasion assays were performed as previously described by Man et al [8]. As C. concisus UNSW1 exhibited decreased sensitivity to gentamicin a modification was made where monolayers were treated with cell culture media containing 100 µg ml−1 penicillin and streptomycin plus 200 µg ml−1 gentamicin during the 1 h incubation to kill any extracellular bacteria.

For the adherence assays, the monolayers were washed four times with antibiotic-free cell culture media to remove extracellular bacteria, and were lysed with 0.5 ml 1% Triton X-100 for 5 min to release internalized bacteria. The lysate solutions from each monolayer were plated in quadruplicate on suitable media. All adherence assays were performed in duplicate and all experiments were repeated three times. Bacterial adherence was calculated by subtracting the internalized bacteria determined using the gentamicin protection assay from the bacterial counts obtained using the adherence assay, and expressed as a relative percentage of inoculated bacteria.

The statistical significance of the differences between the levels of adherence and invasion (mean ± standard deviation) achieved by the different strains of C. concisus was determined using the unpaired t-test using Prism GraphPad version 5.0 (GraphPad Software; San Diego, CA, USA).

Antibiotic susceptibility testing

As gentamicin failed to kill all extracellular C. concisus UNSW1, the susceptibility of C. concisus UNSW1 to gentamicin was examined using the Epsilometer (E)-test system according to the manufacturer's instructions (AB Biodisk; Solna, Sweden). Based on the E-test, the minimum inhibitory concentration (MIC) of gentamicin required to inhibit C. concisus UNSW1 was 1.5 µg ml−1. Unfortunately, no adequate standard for gentamicin susceptibility testing for Campylobacter strains are available [14], and thus, we were unable to determine if C. concisus UNSW1 fell into the susceptible, intermediate or resistant category. Despite this, the MIC value for UNSW1 is considerably higher than that previously reported for other C. concisus strains (∼0.03 µg ml−1) examined by Vandenberg et al [15]. This reduced susceptibility is likely to explain the failure of gentamicin to successfully kill the extracellular C. concisus UNSW1.

Scanning Electron Microscopy

Caco-2 or LS174T cells were grown at 37°C with 5% CO2 on poly-L-lysine coated glass cover slips in 24-well plates at a concentration of 5×105 cells per well for 2 and 5 days, respectively. Cells were then infected with bacteria at a MOI of 200 and samples were visualized on a Hitachi S3400-X Scanning Electron Microscope (Hitachi High-Technologies Corporation; Tokyo, Japan) as previously described [8].

Plasmid purification and PCR

Plasmid DNA was extracted and purified using the low copy number protocol from the HiYield Plasmid mini kit (Real Biotech Corporation; Banqiao City, Taipei County, Taiwan). Circular plasmid visualization was performed using the CGView web-server. The exotoxin 9 PCR was performed using the primer pair exotox-F (GAGACAAAGCTGCTTTAT) and exotox-R (CTATCAAGATTAAAGCCG), which amplifies a 291 bp region. The thermal cycling conditions for this reaction was: 94°C for 5 min, 30 cycles of 94°C for 20 s, 53°C for 20 s, and 72°C for 30 s, followed by 72°C for 5 min.

Preparation of cell-free protein extracts for two-dimensional electrophoresis

To study the effects of C. concisus UNSWCD on the human proteome, Caco-2 cells were grown with and without bacteria (MOI 200) at a density of 2×105 cfu ml−1. Cyclohexamide was added to human cell cultures after 48 h of co-incubation with C. concisus. Cultures were detached and centrifuged at 300× g for 10 min at 4°C, and the pellet was washed three times with 0.2 M ice cold sucrose. After the final wash, the cell pellet was disrupted by twice freeze-thawing, sonication with a Branson sonifier for five cycles of 30 s at an amplitude of 30% keeping the cell suspension in ice, and resuspended in 1 ml TSU buffer (50 mM Tris pH 8.0, 0.1% SDS, 2.5 M urea). Estimation of the protein content of the samples was performed using the bicinchoninic acid method employing a microtitre protocol (Pierce; Rockford, ILL, USA). Absorbances were measured using a Beckman Du 7500 spectrophotometer.

Two-dimensional polyacrylamide gel electrophoresis and mass spectrometry

Strip rehydration, isoelectric focusing and SDS-PAGE were carried out according to the protocol supplied with the ReadyStrip IPG strips (Bio-Rad). For each strip, protein aliquots (200 µg) were suspended in 245 µl of a rehydration buffer consisting of 8 M urea, 100 mM DTT, 65 mM CHAPS, 40 mM Tris-HCl pH 8.0, 10 µl pH 4–7 and IPG buffer. Nuclease buffer (5 µl) was added, and the mixture was incubated at 4°C for 20 min. The sample was then centrifuged at 7230× g for 15 min at 4°C, and the supernatant loaded for the first dimension chromatography onto an 11 cm ReadyStrip IPG (Bio-Rad) of the appropriate pI range, and left to incubate sealed for 24 h at room temperature. Isoelectric focusing was performed using an IsoeletrIQ™ Focusing System (Proteome Systems; Sydney, NSW, Australia). The machine was programmed to run at 300 V for 4 h, 10,000 V for 8 h, and 10,000 V for 22 h or until 80,000 Vh was reached. After focusing, strips were equilibrated sequentially in two buffers of 6 M urea, 20% (w/w) glycerol, 2% (w/v) SDS, 375 mM Tris-HCl, the first one contained 130 mM DTT, and the second one contained 135 mM IA. Strips were rinsed briefly with 25% 1.5 M pH 8.0 Tris before SDS-PAGE was performed using Criterion 12.5% Tris-HCl Precast gels (Bio-Rad), run at 200 V for approximately 45 min. Gels were fixed individually in 0.1 l fixing solution (50% (v/v) methanol, 10% (v/v) acetic acid) for a minimum of 1 h, and were subsequently stained using a sensitive ammoniacal silver method based on silver nitrate.

For comparative gel-image analysis, statistical data were acquired and analyzed using PDQuest 2-D (Bio-Rad). Statistical analyses (Student t test, 95% confidence interval) were performed on three gels from each condition to determine the differential spot intensities between both conditions. Protein spots showing two-fold or more differences in intensity between both experimental conditions (with and without bacteria) were washed twice for 10 min in 100 mM NH4HCO3, reduced at 37°C for 1 h with 10 mM DTT, alkylated for 1 h in 10 mM iodoacetamide, washed for 10 min in 10 mM NH4HCO3, dehydrated in acetonitrile, and trypsin-digested with 10 ng/µl of trypsin. After digestion for 14 h at 37°C, peptides were extracted by washing the gel slice for 15 min with 25 µl 1% formic acid, followed by dehydration in acetonitrile. Digests were then dried in vacuo, resuspended in 10 µl 1% formic acid. Proteins were separated by nano-LC using an Ultimate/Famos/Switchos system (LC Packings, Dionex). Samples (5 µl) were loaded on to a C18 precolumn (Micron; 500 µm×2 mm) with buffer A (98% H2O, 2% CH3CN, 0.1% formic acid) and eluted at 25 µl/min. After a 4 min wash, the flow was switched into line with a C18 RP analytical column (PEPMAP; 75 µm×15 cm) and eluted for 30 min using buffer A at 200 nl/min. Liquid chromatography–tandem mass spectrometry (LC-MS/MS) analysis was performed using a Quadrupole-TOF (Q-TOF) Ultima mass spectrometer. The Q-TOF instrument was operated in data-dependent acquisition mode. A time-of-flight mass spectrometry survey scan was acquired (1 s), and the most intense ions present in the spectrum were selected sequentially by Q1 for tandem MS analysis. Database searches with the Mascot search engine (Matrix Science Ltd.; Boston, MA, USA) were performed and proteins were identified with high confidence according to the matching scores and p-values. Pathway analysis on the regulated proteins was performed using IPA® (Ingenuity Systems; Redwood City, CA, USA).

ELISA

To study the effects of C. concisus strains isolated from subjects with CD, acute gastroenteritis and a healthy control and E. coli on the secretion of cytokines, THP-1 cells were grown with and without bacteria (MOI 200) at a density of 2×105 cfu ml−1. The supernatants were collected, and the levels of interleukin-12 (IL-12) +p40 and interferon-γ (IFN-γ) secreted into the supernatant by differentiated THP-1 cells (these monocyte-derived macrophages were employed as IL-12 is produced by macrophages) were measured using the human IL-12 ELISA kit (Invitrogen) and the human IFN-γ ELISA kit (Invitrogen) according to the manufacturer's instructions.

Results and Discussion

Previous epidemiological studies have shown a significant association between C. concisus and newly diagnosed CD [6], [7]. Preliminary investigations of a C. concisus strain isolated from an intestinal biopsy of a child with CD have shown this strain to have the ability to invade Caco-2 cells [8]. While this preliminary study would suggest that C. concisus from CD patients can invade epithelial cells, further studies on additional clinical isolates were essential to confirm this finding.

Isolation of Campylobacter concisus from intestinal biopsies of patients

Our novel two-step enrichment-filtration procedure was used in an attempt to isolate MAB from 11 intestinal biopsies collected from children undergoing colonoscopy (Table 1). This resulted in the isolation of three C. concisus strains from three individual children (Table 1). Upon further examination, only 6 of the 11 patients were found to be Campylobacter-positive using a previously validated Campylobacter-specific PCR [6], thus the isolation rate for C. concisus in this study was 50%. This isolation rate is higher than that reported by Zhang et al who isolated C. concisus from only 1 of 18 biopsies (5.5%), all of which were C. concisus-PCR positive [6]. In addition to C. concisus, a further MAB was isolated, namely Desulfovibrio fairfieldensis (Table 1), which has been implicated in bacteremia and gastrointestinal diseases [16], [17]. This latter isolate was not investigated in the current study.

thumbnail
Download:
Table 1. Mucosa-associated bacteria isolated from child intestinal biopsies using the Ham's F-12 enrichment-filtration method.

https://doi.org/10.1371/journal.pone.0029045.t001

Investigation of the invasive and adherence potential of Campylobacter concisus

It has been recognized that host cell invasion represents a major virulence factor of C. jejuni, a clear correlation between the invasiveness and the pathogenic potential of specific strains having been reported [18]. Adherence of C. jejuni to host cells has also been shown to be a critical step for host cell invasion [19], [20]. Given this, we evaluated the ability of eight strains of C. concisus isolated from children with chronic intestinal diseases (UNSWCD, UNSW2, UNSW3 and UNSW1), acute intestinal diseases (BAA-1457, UNSWCS and ATCC 51562) and a health control (ATCC 51562) to adhere to and invade the intestinal epithelial cell line Caco-2.

At a MOI of 200 C. concisus UNSWCD was observed to be the most efficient among the 3 CD strains, followed by C. concisus UNSW3, and then C. concisus UNSW2 (Table 2). Interestingly, the level of invasion observed for C. concisus UNSW1 at a MOI of 200 was similar to that of C. concisus UNSWCD (Table 2). The levels of invasion quantified for the ATCC 51562 and UNSWCS isolated from a patients with acute gastroenteritis were negligible as compared with the chronic strains, whereas no invasion was observed for BAA-1457 and ATCC 51561 (Table 2).

thumbnail
Download:
Table 2. Comparison of the percentage invasion and adherence into Caco-2 cells of eight Campylobacter concisus strains.

https://doi.org/10.1371/journal.pone.0029045.t002

The results of the adherence assays at a MOI of 200 showed that the percentage adherence for six of the C. concisus strains was very similar (Table 2). The level of adherence observed in C. concisus UNSW2, C. concisus UNSW3, C. concisus UNSW1, C. concisus BAA-1457 and C. concisus UNSWCS were not significantly different to that in C. concisus UNSWCD. Interestingly, the levels of adherence for ATCC 51562 and ATCC 51561 were significantly different to the other six strains (Table 2).

These results would suggest that although all four C. concisus strains isolated from chronic intestinal diseases have similar abilities to adhere to Caco-2 cells, the percentage invasion into the Caco-2 cell line remained strain-dependent. While significant differences were observed in the percentage invasion of the four chronic strains examined, they all showed significantly increased adherence and invasion as compared with the percentages observed for the acute gastroenteritis strain (ATCC 51562) and a non-invasive healthy control strain (ATCC 51561). Indeed, the percentages of invasion observed for C. concisus UNSW2, C. concisus UNSW3, C. concisus UNSWCD, and C. concisus UNSW1 were 500, 708, 979 and 1021 times higher than that found for C. concisus ATCC 51562, respectively. Interestingly, C. concisus BAA-1457 had similar adherence levels to the chronic strains yet did not invade host cells, suggesting this strain could have a unique mechanism of pathogenesis. These results indicate that the pathogenic potential of C. concisus strains isolated from patients with chronic intestinal diseases is higher than those of strains isolated from patients with acute intestinal diseases and healthy controls. Based on these findings it could be postulated that C. concisus strains associated with chronic intestinal diseases may belong to the same genomospecies, while those strains associated with acute gastroenteritis and healthy controls may belong to different genomospecies.

Visualization of Campylobacter concisus adherence and invasion to host cells

Scanning electron microscopy (ScEM) was used to further investigate the mechanisms employed by the four highly invasive C. concisus strains (UNSWCD, UNSW1, UNSW2, UNSW3) to adhere to and invade the human intestinal cell lines Caco-2 and LS174T. The typical morphologies of C. concisus strains UNSW2, UNSW3, UNSW1 and UNSWCD are shown in Figures 1A, B, C and D, respectively.

thumbnail
Download:
Figure 1. Scanning electron microscopy of four Campylobacter concisus strains.

C. concisus UNSW2 was observed as spiral curved-shaped bacteria with rounded ends and a single polar flagellum as shown in Panel A (bar = 3 µm). In Panel B (bar = 1.5 µm) C. concisus UNSW3 was observed to be curved-shaped bacteria with rounded ends and a single polar flagellum, while in Panels C (bar = 2 µm) and D (bar = 2.5 µm) C. concisus strains UNSW1 and UNSWCD were shown to be spiral curved-shaped bacterium with rounded ends and a single flagellum.

https://doi.org/10.1371/journal.pone.0029045.g001

ScEM clearly illustrated that the four C. concisus strains investigated had similar host epithelial cell-bacterial interactions. Given this, representative ScEM images have been used to portray the interactions between C. concisus and Caco-2 cells (Figure 2). An overview of uninfected Caco-2 cells (Figure 2A) showed the expression of intact differentiating and differentiated microvilli on the surface of Caco-2 monolayers (Figures 2A1, 2A2). C. concisus tended to aggregate upon interaction with the host cells (Figures 2B, 2B1, 2B2). C. concisus mediated initial contact with host cells via flagellum-microvilli interactions, their polar flagellum binding to the tips of different host cell microvilli (indicated by arrows in Figure 2C). Unlike areas where no C. concisus infection was found (indicated by an asterisk in Figure 2D), abnormalities in the microvilli and host cell structures were observed in areas where bacterial infection was present (indicated by a ring in Figure 2D and arrows in Figure 2E). Following adherence, C. concisus appeared to induce a “membrane ruffling”-like effect on the host cell membrane (indicated by an asterisk in Figure 2F) with penetration of the host cell membrane occurring from the non-flagellated end (indicated by arrows in Figures 2G, 2H, 2I). Invasion of bacteria into the host cell was associated with irregular shaped membrane protrusions (indicated by asterisks in Figures 2G, 2H, 2I) with the uptake of C. concisus, resulting in bacteria inducing host cell damage (indicated by “#” in Figures 2G, 2H, 2I).

thumbnail
Download:
Figure 2. Scanning electron microscopy of human intestinal cell line Caco-2 infected with Campylobacter concisus strains for six hours.

Panel A shows an overview of uninfected Caco-2 monolayer. The Caco-2 cells expressed differentiating microvilli (Panel A1) and differentiated microvilli (Panel A2). C. concisus was shown to aggregate upon interaction with host cells as shown in Panel B (Panel B1, bar = 1.5 µm and Panel B2, bar = 2 µm). In Panel C, the polar flagellum of C. concisus is shown binding to the tips of host cell microvilli which mediated initial contact with host cells (as indicated by the arrows). Abnormalities in the epithelial host cell structure and microvilli were observed following infection with C. concisus (indicated by a ring in Panel D and arrows in Panel E). Panel F shows the flagellum of C. concisus appeared to wrap itself around the microvilli (as indicated by arrows). Following adherence, C. concisus induced a “membrane ruffling”-like effect on the host cell membrane (indicated by an asterisk in Panel F), and penetrated the host cell membrane from the non-flagellated end (indicated by an arrow in Panel G). C. concisus was observed invading the host cell (indicated by arrows in Panels G, H and I) resulting in irregular shaped membrane protrusions (indicated by asterisks in Panels G, H and I), leading to host cell damage (indicated by “#” in Panels G, H and I).

https://doi.org/10.1371/journal.pone.0029045.g002

The cell line LS174T exhibits characteristics of enterocyte-morphology and is able to produce a mucin layer in in vitro culture, thus, more closely mimicking the human gastrointestinal tract [21]. Further investigation of these C. concisus strains using the cell line LS174T was considered to be important as this novel model provides the opportunity to study in vitro the role of mucus on the pathogenic behavior of C. concisus strains. ScEM clearly revealed that all four C. concisus strains had very similar host epithelial cell-bacterium interactions on LS174T cells (Figure 3). An overview of uninfected LS174T cells (Figure 3A) showed the expression of differentiated goblet cells (indicated by an arrow in Figure 3B) with sparse microvilli (indicated by a ring in Figure 3B) being observed on the apical surface of LS174T monolayers. The mucus layer (indicated by an “#” in Figure 3C) was observed on the monolayer surface of LS174T cells. C. concisus appeared to be attracted to the intestinal mucus layer (indicated by arrows in Figure 3D) using their single polar flagellum (indicated by arrows in Figure 3E). The bacteria aggregated upon interaction with the mucus layer of the LS174T cells (more bacterial aggregation was observed for LS174T cells than Caco-2 cells) (Figure 3F). C. concisus used its flagellum (indicated by an arrow in Figure 3G) to adhere to the microvilli (indicated by a ring in Figure 3G) and goblet cells (indicated by an arrow in Figure 3H) of the LS174T monolayers which appeared to mediate initial contact with host cells. Following adherence, C. concisus induced a “membrane ruffling”-like effect (indicated by an asterisk in Figure 3I) on the host cell membrane and appeared to penetrate host cell membrane from the non-flagellated end (indicated by an arrow in Figure 3I), leading to host cell damage (indicated by “#” in Figure 3I).

thumbnail
Download:
Figure 3. Scanning electron microscopy of human mucin producing intestinal cell line LS174T infected with Campylobacter concisus strains for six hours.

Panel A shows uninfected LS174T monolayers. LS174T cells expressing microvilli (indicated by a ring) and goblet cells (indicated by a arrow) are shown in Panel B. The mucus layer was found on the monolayer surface of LS174T cells as indicated by an “#” in Panel C. C. concisus appeared to be attracted to the mucus layer of host cells (indicated by “#” in Panel D) using their single polar flagellum (indicated by arrows in Panel E) and upon the interaction with host cells tended to aggregate (Panel F). Panel G shows the polar flagellum (as indicated by an arrow) of C. concisus binding to the tips of host cell microvilli (as indicated by a ring) and goblet cells (as indicated by an arrow in Panel H) which appeared to mediate initial contact with host cells. Following adherence, C. concisus induced a “membrane ruffling”-like effect on the host cell membrane (indicated by an asterisk in Panel I) and penetrated the host cell membrane from the non-flagellated end (indicated by an arrow in Panel I) resulting in cell damage (indicated by “#” in Panel I).

https://doi.org/10.1371/journal.pone.0029045.g003

Previous studies have shown that C. jejuni expresses the fibronectin-binding outer membrane protein (CadF) that mediates adherence by binding to the cell matrix protein fibronectin located on epithelial cells [22], [23]. CadF is involved in the “membrane ruffling” observed prior to C. jejuni invasion [24]. Moreover, ScEM studies have shown that C. jejuni enters intestinal cells with its tip followed by the flagellar end [24]. Our findings that C. concisus secretes the outer membrane fibronectin binding protein [9], is associated with a “membrane ruffling”-like effect on the intestinal cell membrane prior to invasion, and that invasion occurred from the non-flagellated end would suggest that C. concisus has a very similar mechanism of invasion to C. jejuni. Interestingly, as aggregation of C. concisus strains upon interaction with the intestinal mucus layer was observed, it is possible that this aggregation of C. concisus may involve biofilm formation. Such aggregation is similar to that previously reported in C. concisus ATCC 33237, which was shown to form biofilms on glass [25].

Investigation of the invasive phenotype of Campylobacter concisus

Investigation of the invasive phenotype of C. concisus was undertaken due to the observed differences in invasive potential among strains isolated from chronic and acute intestinal diseases. One feature of interest was a 30 kb plasmid that we had recently detected in UNSWCD and that was different to the two plasmids found in BAA-1457 [26]. Assembly of the C. concisus UNSWCD plasmid sequence was performed in this study using sequencing data generated in a previously published study [26]. The plasmid contained several virulence determinants from various organisms not closely related to C. concisus (Figure 4). Genes within this plasmid encoded the toxin-antitoxin (TA) replicon stabilization system StbD and StbE, mobilization protein MobA, exotoxin 9, restriction endonuclease R.Ecl19kI, DNA-cytosine methyltransferase, two site-specific recombinases, TonB-dependent receptor, mature parasite-infected erythrocyte surface antigen (MESA), a sodium/solute symporter, choline kinase, glycosyl transferase, a membrane spanning protein, 3 stress-related proteins and 10 hypothetical proteins. Importantly, analysis of C. concisus UNSWCD whole lysate expression data generated in a previously published study [26] revealed several of the proteins encoded by these genes were expressed under normal growth conditions.

thumbnail
Download:
Figure 4. Graphical representation of the genes encoded by the plasmid purified from Campylobacter concisus UNSWCD.

Outer circle (blue) represents the coding sequences within the plasmid; inner circle (black) represents the GC content; inner circle (purple/green) represents the GC skew.

https://doi.org/10.1371/journal.pone.0029045.g004

The plasmid contains a TA system that is composed of two components, a stable toxin and an unstable antitoxin that interferes with the lethal action of the toxin. StbD and StbE homologues are commonly found in other pathogenic bacteria such as Vibrio cholerae and Haemophilus influenzae, a finding that suggests that they may have a function in virulence [27]. Of particular interest, were two genes encoding a Gram-positive exotoxin 9 and MESA. Exotoxin 9 has very high homology with exotoxins in Gram-positive bacteria, and contains a CYCLIN domain within its sequence. Cyclin homologues have been found in various viruses, where these viral homologues differ from their cellular counterparts in that the viral proteins are modified to harness the cell and benefit the virus [28]. MESA has been found to play a major role in intra-erythrocytic malarial viability [29]. It competes with P55 for the erythrocyte skeletal muscle protein, and hence regulates stability and mechanical properties of the erythrocyte plasma membrane [30]. Although the ubiquitously expressed P55 has been identified as a scaffolding protein in erythrocytes that stabilizes the actin cytoskeleton to the plasma membrane, its function in non-erythroid cells remains poorly understood [30]. Recently, P55 has been found to regulate neutrophil polarity, and function as a positive upstream effector of Akt phosphorylation [31]. Thus, the competition of MESA with P55, and the functional role of P55 in the host may imply that C. concisus UNSWCD employs this protein to modulate the host innate immune response.

The presence of this plasmid was investigated in the other seven strains through a PCR targeting the gene encoding the exotoxin 9, and significantly, the four highly invasive strains from chronic intestinal diseases (UNSWCD, UNSW1, UNSW2 and UNSW3) were the only strains to contain this gene (Figure 5). Four further plasmid genes (encoding: DNA-cytosine methyltransferase, mobilization protein MobA, site-specific recombinase and restriction endonuclease R.Ecl18kl) were confirmed to be present in the chronic strains and absent in the other four strains (data not shown). This provides further evidence that this plasmid, with the possibility of some minor modifications, may be responsible for the heterogeneity in the invasive potential of C. concisus.

thumbnail
Download:
Figure 5. PCR analysis of the exotoxin 9 gene in the eight Campylobacter concisus strains.

Lane 1: FN-1 marker, lane 2: UNSWCD, lane 3: UNSW2, lane 4: UNSW3, lane 5: UNSW1, lane 6: BAA-1457, lane 7: UNSWCS, lane 8: ATCC 51562, lane 9: ATCC 51651 and lane 10: negative control.

https://doi.org/10.1371/journal.pone.0029045.g005

Effect of Campylobacter concisus on host cell protein expression

The effect of C. concisus UNSWCD on host cells was examined by determining the change in protein expression upon infection with the bacterium. The response of Caco-2 cells to C. concisus UNSWCD infection was analyzed using 2D gel electrophoresis to determine the changes in the proteome of the human cells (Figure 6). 2D gel electrophoresis was performed on proteins extracted from pairs of human cultures grown with and without C. concisus; they included four independent biological repeats. The four pairs of gels obtained from cultures under both conditions were analyzed to identify, using tandem mass spectrometry, spots corresponding to proteins whose expression was regulated upon infection with bacteria. One hundred and twenty five proteins were differentially expressed (6.71% of the total spots detected on the gels), of which 78 were upregulated and 47 were downregulated in the presence of C. concisus (Tables 3 and 4, respectively; Table S1 and S2).

thumbnail
Download:
Figure 6. Two-dimensional proteomes of (A) non-infected Caco-2 cells (pI 4–7), (B) Caco-2 cells infected with C. concisus UNSWCD (pI 4–7), (C) non-infected Caco-2 cells (pI 7–10), and (D) Caco-2 cells infected with C. concisus UNSWCD (pI 7–10).

Proteins differentially expressed between the two growth conditions are listed in Table 3 and Table 4. Spot numbers correspond to numbers in Table S1 and Table S2.

https://doi.org/10.1371/journal.pone.0029045.g006

thumbnail
Download:
Table 3. Caco-2 cell proteins whose expression is upregulated in the presence of Campylobacter concisus UNSWCD.

https://doi.org/10.1371/journal.pone.0029045.t003

thumbnail
Download:
Table 4. Caco-2 cell proteins whose expression is downregulated in the presence of Campylobacter concisus UNSWCD.

https://doi.org/10.1371/journal.pone.0029045.t004

Analysis of the response of Caco-2 cells to C. concisus infection revealed a significant impact on host cell metabolism, specifically, the upregulation of creatine kinase (CK) and processes involved in energy production, and inhibition of proteases (Tables 3, 4). CK catalyzes the conversion of creatine to phosphocreatine (PCr) through the consumption of adenosine triphosphate (ATP). PCr serves as an energy reservoir for the rapid buffering and regeneration of ATP in situ, as well as for intracellular energy transport by the PCr shuttle [32]. The increase in energy production through enzymes such as ATP synthase, dihydrolipoamide succinyltransferase, enoyl coenzyme A hydratase, enolase, fumarate dehydratase, GAP dehydrogenase, isocitrate dehydrogenase, malate dehydrogenase, pyruvate dehydrogenase and pyruvate kinase indicate that the cells are producing more energy to combat the damage caused by bacterial infection. In addition, it appears that the cells have downregulated the activity of proteases either directly through the downregulation of cathepsin D or indirectly through the upregulation of serpin peptidase inhibitors. This may relate to the fact that during infection bacteria produce proteases that target the innate immune response and degrade host proteins [33].

One likely avenue for the increase in energy production is for reinforcement of the structural integrity of the cell following cellular damage by the bacteria. This is supported by the upregulation of an actin-related protein and the downregulation of Hsp27, a heat shock protein known to inhibit F-actin polymerization [34]. Interestingly, we observed the downregulation of cofilin, a protein that is known to promote rapid actin filament turnover through severing actin filaments [35]. One possible explanation for this downregulation is that following C. concisus infection, host cells protect themselves against further severing of actin filaments. Moreover, β-tubulin was upregulated and stathmin was downregulated, a finding that further supports the view that the cell was strengthening its structural integrity, given that stathmin is known to promote microtubule disassembly by sequestering β-tubulin into the tight ternary T2S complex thereby rendering it non-polymerizable [36].

Another indication that C. concisus affected the structural integrity of the cell monolayer was the upregulation of desmoplakin. This protein is an essential component of functional desmosomes, intercellular junctions that tightly link adjacent cells, and is responsible for anchoring intermediate filaments to desmosomal plaques [37]. This finding is supported by our previous study that showed C. concisus UNSWCD to preferentially attach to intercellular junctional spaces, and that this spatial distribution was concomitantly associated with a loss of membrane-associated ZO-1 and occludin [8].

IPA analysis revealed that the pathway involved in the production of IL-12 was upregulated in cells exposed to C. concisus UNSWCD, 28 proteins directly or indirectly involved in the IL-12 pathway being found to be upregulated (Figure S1). Those proteins directly involved in the production of IL-12 complex, included fuse binding protein 1, nuclear distribution gene C homolog, heat shock protein 90 kDa beta, endoplasmic reticulum protein 44, serpin peptidase inhibitor clade A, apolipoprotein C-III, voltage-dependent anion channel 1 and SET nuclear oncogene (Figure S1). IL-12 is of particular interest due to its induction of intestinal mucosal inflammation through an IFN-γ- dependent manner [38]. The significance of this cytokine is discussed further below.

Infection of Caco-2 cells with C. concisus resulted in the upregulation of three proteins involved in the proteasome complex, namely the proteasome 26S subunit ATPases 3, 5 and 6. In conjunction with this, ubiquitin-conjugating enzyme E2 and ubiquinol-cytochrome c reductase, which are involved in protein ubiquitination were upregulated, and ubiquitin thiolesterase, which is involved in protein deubiquitination, was downregulated. Proteasomes are part of the protein degradation machinery of the cell that regulate the concentration of particular proteins and degrade misfolded proteins [39]. In this process, proteins are initially tagged for degradation with a small protein called ubiquitin, which provides a signal to other ubiquitinating enzymes to attach additional ubiquitin molecules, thus forming a polyubiquitin chain that is bound by the proteasome, thereby allowing it to degrade the tagged protein [40].

One indication that NF-κB might be activated upon infection with C. concisus UNSWCD is the upregulation of the proteasome and protein ubiquitination pathways that are involved in the degradation of NF-κB inhibitors [41]. Direct evidence of NF-κB activation upon infection comes from the finding that one pathway leading to the ser/thr kinase Akt is upregulated, namely the proteins ATPase, EEF1G, ATP5B, P4HB, PDIA3, CALR and RPS14 (Figure S2). Akt functions through Iκβ kinase (IKK) to promote the transactivation potential and phosphorylation of NF-κB [42], [43]. More recently, Akt has been found to promote IKK-dependent activation of NF-κB via mTOR and Raptor [44].

Further evidence includes the downregulation of NF-κB inhibitors such as annexin 1 (ANXA1) and prohibitin (PHB). ANXA1 has been found to suppress the transcriptional activity of NF-κB by preventing it from binding to DNA [45]. This inhibitory activity has also been found in the intestinal mucosa of mice treated with an agent that induces ANXA1 [45]. Furthermore, PHB has been found to decrease TNF-α-induced nuclear translocation of the NF-κB protein p65, NF-κB/DNA binding, and NF-κB-mediated transcriptional activation in vitro and in vivo, despite continual IκB-α phosphorylation and degradation and increased cytosolic p65 [46]. The downregulation of polyamine-modulated factor 1 (PMF1), a binding partner of NF-E2 related factor-2 (Nrf2), was a further indication that NF-κB was activated. PMF1 binds to Nrf2 to regulate gene transcription [47]. Nrf2 over-expression has been shown to suppress NF-κB DNA binding activity [48]. Furthermore, it has been suggested that Nrf2 activation induces intracellular events that concur with NF-κB suppression [49].

Cytokine production in response to Campylobacter concisus infection

Proteomics coupled with tandem mass spectrometry established that the pathway leading to the production of IL-12 was upregulated in cells infected with C. concisus UNSWCD. Thus, we confirmed using ELISA the production of IL-12 in monocyte-derived macrophages upon infection with the eight C. concisus strains and E. coli K-12. Significantly increased levels of IL-12 were found to be produced in cells exposed to C. concisus UNSWCD as compared with controls (Figure 7), thereby validating the expression results observed through proteomics. However, cells exposed to any of the eight C. concisus strains were also found to produce significantly increased levels of IL-12 as compared with controls (Figure 7), indicating that production of IL-12 upon exposure to C. concisus does not correlate with the pathogenic potential of the bacterium. Cells exposed to E. coli K-12 or no bacteria produced negligible amounts of IL-12 (Figure 7), confirming that the production of IL-12 by cells exposed to C. concisus was due to the bacterium. While it is possible that a small amount of the measured IL-12 may have resulted from IL-23, due to the two cytokines sharing the p40 subunit [50], our proteomics findings and the high levels measured (>600 pg ml−1) both support the importance of IL-12 in C. concisus infection.

thumbnail
Download:
Figure 7. Levels of interleukin-12 and interferon-γ produced by the human monocytic leukemia cell line THP-1 following infection with Campylobacter concisus strains and Escherichia coli K-12.

* represents P<0.05; ** represents P<0.01. Data of three independent experiments ± standard error of the mean.

https://doi.org/10.1371/journal.pone.0029045.g007

IL-12 is known to stimulate mouse peritoneal macrophages to express and secrete IFN-γ [51]. In addition, IFN-γ promotes the accumulation of immunoproteasomes [52], and both in vitro and in vivo IFN-γ is essential for upregulation of immunoproteasome subunits in mice [53]. Together with the upregulation of the proteasome in our study, these findings led us to investigate the production of IFN-γ in cells infected with C. concisus. This showed that only C. concisus strains that were capable of invading into human cells stimulated the production of IFN-γ, with C. concisus UNSWCD inducing the highest quantity of this cytokine (Figure 7). This was of particular significance as although all strains of C. concisus produced high amounts of IL-12, only the C. concisus strains capable of internalizing into host cells induced a significantly increased quantity of IFN-γ with respect to both controls.

Overall our findings suggest that non-invasive C. concisus strains can induce IL-12 upon adherence to human cells, however, this does not translate to the production of IFN-γ (Figure 8). In contrast, in human cells exposed to invasive C. concisus strains, the production of IL-12 results in the induction of IFN-γ, which in turn activates the immunoproteasome (Figure 8). Concurrently, the human cells exposed to the invasive C. concisus strains regulate ubiquitination pathways and these enzymes tag NF-κB inhibitors for degradation by the immunoproteasome, leading to the activation of NF-κB (Figure 8). These findings are of great significance when the association of C. concisus with pediatric CD [6], [7] is taken into consideration. The tissue damaging inflammatory reaction in CD is driven by activated type 1 helper T-cells (Th1), with IL-12 being a major Th1-inducing factor, a view that is supported by the observation that an accumulation of macrophages making IL-12 occurs in CD patients [54]. Further evidence of the importance of IL-12 in CD is the finding that administration of a monoclonal antibody blocking the IL-12/p40 subunit can induce and maintain clinical remission in CD patients [55]. Significantly in relation to our findings, the 26S proteasome has been shown to play an important role in the inflammatory cascade and chronic gut inflammation in particular in CD [56]. Indeed, high expression of immunoproteasome subunits and enhanced processing of the NF-κB precursor p105 and degradation of the NF-κB inhibitor, IκBα, by immunoproteasomes is a characteristic of the inflamed mucosa of CD patients [57]. Enhanced NF-κB activity has also been shown to be involved in the pathology of CD [57]. Furthermore, our finding that PHB, an NF-κB inhibitor, was downregulated upon infection of cells with C. concisus UNSWCD, is in line with the decreased expression of PHB reported in subjects with CD [58].

thumbnail
Download:
Figure 8. Proposed immune response to Campylobacter concisus UNSWCD.

(A) Non-invasive C. concisus strains adhere to the host cell and induce the production of IL-12. (B) Invasive C. concisus strains adhere to and invade the host cell inducing both IL-12 and IFN-γ, which in turn activate the immunoproteosome. The bacterial insult upregulates ubiquitinating and downregulates de-ubiquitinating enzymes which leads to the ubiquitination of NF-κB inhibitors. The immunoproteosome targets these inhibitors which activates NF-κB.

https://doi.org/10.1371/journal.pone.0029045.g008

Conclusions

This study has not only provided novel information on the mechanisms by which C. concisus strains interact with host intestinal cells, but has also provided important evidence that strains of C. concisus isolated from patients with chronic intestinal diseases have a significantly increased ability to invade intestinal cell lines as compared with C. concisus strains isolated from patients with acute gastroenteritis and healthy controls. Importantly, we have elucidated the feature that may be responsible for the heterogeneity in invasive potential of C. concisus. Moreover, this study has revealed novel information on the host immune response to C. concisus infection, and has shown that this response has substantial similarities with that observed in the mucosa of CD patients.

Supporting Information

Figure S1.

Network associated with the production of IL-12 generated through IPA® (Ingenuity Systems). Proteins colored in grey were upregulated. Proteins highlighted with an asterisk were directly associated with the IL-12 complex.

https://doi.org/10.1371/journal.pone.0029045.s001

(PPT)

Figure S2.

Network associated with the upregulation of Akt generated through IPA® (Ingenuity Systems). Proteins colored in grey were upregulated. Proteins highlighted with an asterisk were associated with one pathway that lead to the expression of Akt.

https://doi.org/10.1371/journal.pone.0029045.s002

(PPT)

Table S1.

Mass spectrometry results of Caco-2 cell proteins whose expression is upregulated in the presence of Campylobacter concisus UNSWCD. Proteins with changes in their intensity ≥2.0-fold (P<0.05) were identified by tandem mass spectrometry analyses. Cut off scores of >58 and ≥2 peptide matches were employed.

https://doi.org/10.1371/journal.pone.0029045.s003

(DOC)

Table S2.

Mass spectrometry results of Caco-2 cell proteins whose expression is downregulated in the presence of Campylobacter concisus UNSWCD. Proteins with changes in their intensity ≤0.5-fold (P<0.05) were identified by tandem mass spectrometry analyses. Cut off scores of >58 and ≥2 peptide matches were employed.

https://doi.org/10.1371/journal.pone.0029045.s004

(DOC)

Acknowledgments

The authors would like to thank Jennifer Norman from the Electron Microscopy unit (UNSW) for her technical assistance.

Author Contributions

Conceived and designed the experiments: NOK HM. Performed the experiments: NOK NPD CGT JAB-P MJR. Analyzed the data: NOK NPD CGT JAB-P MJR MRW ASD DAL HM. Contributed reagents/materials/analysis tools: MRW ASD DAL HM. Wrote the paper: NOK HM. Provided human samples: ASD DAL.

References

  1. 1. Cho JH, Abraham C (2007) Inflammatory bowel disease genetics: Nod2. Annu Rev Med 58: 401–416.
  2. 2. Theodossi A, Spiegelhalter DJ, Jass J, Firth J, Dixon M, et al. (1994) Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut 35: 961–968.
  3. 3. Sartor RB (2006) Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3: 390–407.
  4. 4. Engberg J, On SL, Harrington CS, Gerner-Smidt P (2000) Prevalence of Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters. J Clin Microbiol 38: 286–291.
  5. 5. On SL (1996) Identification methods for campylobacters, helicobacters, and related organisms. Clin Microbiol Rev 9: 405–422.
  6. 6. Zhang L, Man SM, Day AS, Leach ST, Lemberg DA, et al. (2009) Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol 47: 453–455.
  7. 7. Man SM, Zhang L, Day AS, Leach ST, Lemberg DA, et al. (2010) Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm Bowel Dis 16: 1008–1016.
  8. 8. Man SM, Kaakoush NO, Leach ST, Nahidi L, Lu HK, et al. (2010) Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J Infect Dis 202: 1855–1865.
  9. 9. Kaakoush NO, Man SM, Lamb S, Raftery MJ, Wilkins MR, et al. (2010) The secretome of Campylobacter concisus. FEBS J 277: 1606–1617.
  10. 10. Aabenhus R, Permin H, On SL, Andersen LP (2002) Prevalence of Campylobacter concisus in diarrhoea of immunocompromised patients. Scand J Infect Dis 34: 248–252.
  11. 11. Sainsus N, Cattori V, Lepadatu C, Hofmann-Lehmann R (2008) Liquid culture medium for the rapid cultivation of Helicobacter pylori from biopsy specimens. Eur J Clin Microbiol Infect Dis 27: 1209–1217.
  12. 12. Lastovica AJ, le Roux E (2000) Efficient isolation of campylobacteria from stools. J Clin Microbiol 38: 2798–2799.
  13. 13. Kaakoush NO, Holmes J, Octavia S, Man SM, Zhang L, et al. (2010) Detection of Helicobacteraceae in intestinal biopsies of children with Crohn's disease. Helicobacter 15: 549–557.
  14. 14. Luber P, Bartelt E, Genschow E, Wagner J, Hahn H (2003) Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli. J Clin Microbiol 41: 1062–1068.
  15. 15. Vandenberg O, Houf K, Douat N, Vlaes L, Retore P, et al. (2006) Antimicrobial susceptibility of clinical isolates of non-jejuni/coli campylobacters and arcobacters from Belgium. J Antimicrob Chemother 57: 908–913.
  16. 16. Loubinoux J, Bronowicki JP, Pereira IA, Mougenel JL, Faou AE (2002) Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol Ecol 40: 107–112.
  17. 17. Urata T, Kikuchi M, Hino T, Yoda Y, Tamai K, et al. (2008) Bacteremia caused by Desulfovibrio fairfieldensis. J Infect Chemother 14: 368–370.
  18. 18. Russell RG, O'Donnoghue M, Blake DC Jr, Zulty J, DeTolla LJ (1993) Early colonic damage and invasion of Campylobacter jejuni in experimentally challenged infant Macaca mulatta. J Infect Dis 168: 210–215.
  19. 19. Bereswill S, Kist M (2002) Molecular microbiology and pathogenesis of Helicobacter and Campylobacter updated: a meeting report of the 11th conference on Campylobacter, Helicobacter and related organisms. Mol Microbiol 45: 255–262.
  20. 20. Ketley JM (1997) Pathogenesis of enteric infection by Campylobacter. Microbiology 143: 5–21.
  21. 21. Tom BH, Rutzky LP, Jakstys MM, Oyasu R, Kaye CI, et al. (1976) Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro 12: 180–191.
  22. 22. Konkel ME, Christensen JE, Keech AM, Monteville MR, Klena JD, et al. (2005) Identification of a fibronectin-binding domain within the Campylobacter jejuni CadF protein. Mol Microbiol 57: 1022–1035.
  23. 23. Konkel ME, Garvis SG, Tipton SL, Anderson DE Jr, Cieplak W Jr (1997) Identification and molecular cloning of a gene encoding a fibronectin-binding protein (CadF) from Campylobacter jejuni. Mol Microbiol 24: 953–963.
  24. 24. Krause-Gruszczynska M, Rohde M, Hartig R, Genth H, Schmidt G, et al. (2007) Role of the small Rho GTPases Rac1 and Cdc42 in host cell invasion of Campylobacter jejuni. Cell Microbiol 9: 2431–2444.
  25. 25. Gunther NWt, Chen CY (2009) The biofilm forming potential of bacterial species in the genus Campylobacter. Food Microbiol 26: 44–51.
  26. 26. Deshpande N, Kaakoush NO, Mitchell H, Janitz K, Raftery MJ, et al. (2011) Sequencing and validation of the genome of a Campylobacter concisus reveals extensive intra-species diversity. PLoS One 6: e22170.
  27. 27. Hayes F (1998) A family of stability determinants in pathogenic bacteria. J Bacteriol 180: 6415–6418.
  28. 28. Hardwick JM (2000) Cyclin' on the viral path to destruction. Nat Cell Biol 2: E203–204.
  29. 29. Magowan C, Coppel RL, Lau AO, Moronne MM, Tchernia G, et al. (1995) Role of the Plasmodium falciparum mature-parasite-infected erythrocyte surface antigen (MESA/PfEMP-2) in malarial infection of erythrocytes. Blood 86: 3196–3204.
  30. 30. Waller KL, Nunomura W, An X, Cooke BM, Mohandas N, et al. (2003) Mature parasite-infected erythrocyte surface antigen (MESA) of Plasmodium falciparum binds to the 30-kDa domain of protein 4.1 in malaria-infected red blood cells. Blood 102: 1911–1914.
  31. 31. Quinn BJ, Welch EJ, Kim AC, Lokuta MA, Huttenlocher A, et al. (2009) Erythrocyte scaffolding protein p55/MPP1 functions as an essential regulator of neutrophil polarity. Proc Natl Acad Sci U S A 106: 19842–19847.
  32. 32. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM (1992) Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis. Biochem J 281(Pt 1): 21–40.
  33. 33. Potempa J, Pike RN (2009) Corruption of innate immunity by bacterial proteases. J Innate Immun 1: 70–87.
  34. 34. Piotrowicz RS, Hickey E, Levin EG (1998) Heat shock protein 27 kDa expression and phosphorylation regulates endothelial cell migration. FASEB J 12: 1481–1490.
  35. 35. Lappalainen P, Drubin DG (1997) Cofilin promotes rapid actin filament turnover in vivo. Nature 388: 78–82.
  36. 36. Jourdain L, Curmi P, Sobel A, Pantaloni D, Carlier MF (1997) Stathmin: a tubulin-sequestering protein which forms a ternary T2S complex with two tubulin molecules. Biochemistry 36: 10817–10821.
  37. 37. Bornslaeger EA, Corcoran CM, Stappenbeck TS, Green KJ (1996) Breaking the connection: displacement of the desmosomal plaque protein desmoplakin from cell-cell interfaces disrupts anchorage of intermediate filament bundles and alters intercellular junction assembly. J Cell Biol 134: 985–1001.
  38. 38. Chikano S, Sawada K, Shimoyama T, Kashiwamura SI, Sugihara A, et al. (2000) IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner. Gut 47: 779–786.
  39. 39. Peters JM, Franke WW, Kleinschmidt JA (1994) Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm. J Biol Chem 269: 7709–7718.
  40. 40. van Deventer S, Neefjes J (2010) The Immunoproteasome Cleans up after Inflammation. Cell 142: 517–518.
  41. 41. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18: 621–663.
  42. 42. Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr (2001) Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276: 18934–18940.
  43. 43. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR (2002) Distinct roles of the IκB kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J Biol Chem 277: 3863–3869.
  44. 44. Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, et al. (2008) Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK. Genes Dev 22: 1490–1500.
  45. 45. Zhang Z, Huang L, Zhao W, Rigas B (2010) Annexin 1 induced by anti-inflammatory drugs binds to NF-κB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 70: 2379–2388.
  46. 46. Theiss AL, Jenkins AK, Okoro NI, Klapproth JM, Merlin D, et al. (2009) Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression. Mol Biol Cell 20: 4412–4423.
  47. 47. Wang Y, Devereux W, Stewart TM, Casero RA Jr (2002) Polyamine-modulated factor 1 binds to the human homologue of the 7a subunit of the Arabidopsis COP9 signalosome: implications in gene expression. Biochem J 366: 79–86.
  48. 48. Song MY, Kim EK, Moon WS, Park JW, Kim HJ, et al. (2009) Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-κB pathway. Toxicol Appl Pharmacol 235: 57–67.
  49. 49. Bellezza I, Mierla AL, Minelli A (2010) Nrf2 and NF-κB and Their Concerted Modulation in Cancer Pathogenesis and Progression. Cancers 2: 483–497.
  50. 50. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715–725.
  51. 51. Puddu P, Fantuzzi L, Borghi P, Varano B, Rainaldi G, et al. (1997) IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J Immunol 159: 3490–3497.
  52. 52. Fabunmi RP, Wigley WC, Thomas PJ, DeMartino GN (2001) Interferon gamma regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies. J Cell Sci 114: 29–36.
  53. 53. Barton LF, Cruz M, Rangwala R, Deepe GS Jr, Monaco JJ (2002) Regulation of immunoproteasome subunit expression in vivo following pathogenic fungal infection. J Immunol 169: 3046–3052.
  54. 54. Peluso I, Pallone F, Monteleone G (2006) Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol 12: 5606–5610.
  55. 55. Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, et al. (2004) Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 351: 2069–2079.
  56. 56. Conner EM, Brand S, Davis JM, Laroux FS, Palombella VJ, et al. (1997) Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. J Pharmacol Exp Ther 282: 1615–1622.
  57. 57. Visekruna A, Joeris T, Seidel D, Kroesen A, Loddenkemper C, et al. (2006) Proteasome-mediated degradation of IκBα and processing of p105 in Crohn disease and ulcerative colitis. J Clin Invest 116: 3195–3203.
  58. 58. Theiss AL, Idell RD, Srinivasan S, Klapproth JM, Jones DP, et al. (2007) Prohibitin protects against oxidative stress in intestinal epithelial cells. FASEB J 21: 197–206.